Overview

  • Product nameAnti-GBE1 antibody
    See all GBE1 primary antibodies
  • Description
    Mouse polyclonal to GBE1
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Horse
  • Immunogen

    Full length human GBE1 protein

  • Positive control
    • GBE1 transfected lysate and human liver lysate

Properties

Applications

Our Abpromise guarantee covers the use of ab67523 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/500 - 1/1000. Detects a band of approximately 73 kDa (predicted molecular weight: 81 kDa).

Target

  • FunctionRequired for sufficient glycogen accumulation. The alpha 1-6 branches of glycogen play an important role in increasing the solubility of the molecule and, consequently, in reducing the osmotic pressure within cells.
  • Tissue specificityHighest levels found in liver and muscle.
  • PathwayGlycan biosynthesis; glycogen biosynthesis.
  • Involvement in diseaseDefects in GBE1 are the cause of glycogen storage disease type 4 (GSD4) [MIM:232500]; also known as Andersen disease. GSD4 is a metabolic disorder characterized by the accumulation of an amylopectin-like polysaccharide. The typical clinical manifestation is liver disease of childhood, progressing to lethal hepatic cirrhosis. Most children with this condition die before two years of age. However, the liver disease is not always progressive. No treatment apart from liver transplantation has been found to prevent progression of the disease. There is also a neuromuscular form of GSD4 that varies in onset (perinatal, congenital, juvenile, or adult) and severity.
    Note=Neuromuscular perinatal glycogen storage disease type 4 is associated with non-immune hydrops fetalis, a generalized edema of the fetus with fluid accumulation in the body cavities due to non-immune causes. Non-immune hydrops fetalis is not a diagnosis in itself but a symptom, a feature of many genetic disorders, and the end-stage of a wide variety of disorders.
    Defects in GBE1 are the cause of adult polyglucosan body disease (APBD) [MIM:263570]. APBD is a late-onset, slowly progressive disorder affecting the central and peripheral nervous systems. Patients typically present after age 40 years with a variable combination of cognitive impairment, pyramidal tetraparesis, peripheral neuropathy, and neurogenic bladder. Other manifestations include cerebellar dysfunction and extrapyramidal signs. The pathologic hallmark of APBD is the widespread accumulation of round, intracellular polyglucosan bodies throughout the nervous system, which are confined to neuronal and astrocytic processes.
  • Sequence similaritiesBelongs to the glycosyl hydrolase 13 family.
  • Information by UniProt
  • Database links
  • Alternative names
    • 1 antibody
    • 1,4 alpha glucan branching enzyme antibody
    • 4-alpha-glucan-branching enzyme antibody
    • amylo (1,4 to 1,6) transglucosidase antibody
    • amylo (1,4 to 1,6) transglycosylase antibody
    • Andersen disease antibody
    • APBD antibody
    • Brancher enzyme antibody
    • GBE 1 antibody
    • GBE antibody
    • GBE1 antibody
    • gGlucan (1,4 alpha ), branching enzyme 1 antibody
    • GLGB_HUMAN antibody
    • Glucan (1,4 alpha) branching enzyme antibody
    • Glycogen branching enzyme antibody
    • Glycogen storage disease type IV antibody
    • Glycogen-branching enzyme antibody
    • GSD4 antibody
    • OTTHUMP00000213788 antibody
    • OTTHUMP00000213833 antibody
    see all

Anti-GBE1 antibody images

  • Anti-GBE1 antibody (ab67523) at 1/500 dilution + GBE1 expression in human liver at 25 µg

    Secondary
    Goat anti-mouse IgG (H&L)-HRP conjugate at 1/2500 dilution

    Predicted band size : 81 kDa
    Observed band size : 73 kDa (why is the actual band size different from the predicted?)
  • All lanes : Anti-GBE1 antibody (ab67523) at 1/500 dilution

    Lane 1 : GBE1 transfected lysate
    Lane 2 : Non-transfected lysate

    Lysates/proteins at 25 µg per lane.

    Secondary
    Goat anti-mouse IgG (H&L)-HRP conjugate at 1/2500 dilution

    Predicted band size : 81 kDa
    Observed band size : 72 kDa (why is the actual band size different from the predicted?)

References for Anti-GBE1 antibody (ab67523)

ab67523 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab67523.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"